Autoimmune hepatitis (AIH): Features of autoimmune liver disease and primary biliary cirrhosis after 33 months of administration of IFN-β was reported in a 42-year-old woman with RRMS. This evidence concerns the gene IFNB1 and autoimmune hepatitis.